Search for:

Examples (hovertap for more info):
term
,
-term
,
/r/subreddit
,
-/r/subreddit
,
site:example.com
,
-site:example.com
,
score:3
,
before:2015-03-15
,
after:2015-03-15
Sort by: newest oldest top
Prognostic value of tumor microenvironment (TME) features in advanced, EGFR-mutant non-small cell lung cancer (NSCLC) | Molecular Cancer Therapeutics 2
/r/nsclc, 2023-12-07, 02:22:13
Disclosing Potential Therapeutic Targets Associated With Osimertinib Resistance in the Non-small Cell Lung Cancer Cell Line H1975 3
/r/nsclc, 2023-12-07, 02:18:27
Unmet Needs in EGFR Exon 20 Insertion Non–Small Cell Lung Cancer 2
/r/nsclc, 2023-12-07, 02:09:31
Impact of Molecular Testing on Lung Cancer Survival: Real-world Insights 2
/r/nsclc, 2023-12-07, 02:09:19
Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer 1
/r/nsclc, 2023-11-29, 02:56:51
First-Line Osimertinib for Uncommon EGFR Mutations and NSCLC 1
/r/nsclc, 2023-11-29, 01:34:56
Proton and photon radiotherapy in stage III NSCLC: effects on hematological toxicity and adjuvant immune therapy 1
/r/nsclc, 2023-11-29, 01:34:17
ctDNA Dynamics, Prognostic Markers, and Mechanisms of Resistance in Tepotinib-treated MET exon 14 (METex14) Skipping NSCLC in the VISION Trial. 1
/r/nsclc, 2023-11-29, 01:32:32
Long non-coding RNA signatures in non-small cell lung cancer and their clinicopathological significanceLncRNA signatures in NSCLC. 1
/r/nsclc, 2023-11-29, 01:29:55
Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial 1
/r/nsclc, 2023-11-29, 01:28:34
Development and Validation of a Machine Learning–Based Model Using CT Radiomics for Predicting Immune Checkpoint Inhibitor-related Pneumonitis in Patients With NSCLC Receiving Anti-PD1 Immunotherapy: A Multicenter Retrospective CaseControl Study 1
/r/nsclc, 2023-11-29, 01:16:43
Discussing Biomarkers and Best Options in NSCLC 1
/r/nsclc, 2023-11-14, 02:02:29
Pembrolizumab Every 6 Weeks Versus Every 3 Weeks in Advanced Non-Small Cell Lung Cancer | The Oncologist 2
/r/nsclc, 2023-07-01, 14:55:43
Efficacy of lazertinib for symptomatic or asymptomatic brain metastases in treatment-naive patients with advanced EGFR mutation-positive non-small cell lung cancer: Protocol of an open-label, single-arm phase II trial 2
/r/nsclc, 2023-07-01, 14:50:05
Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis. - Abstract 2
/r/nsclc, 2023-06-19, 00:03:29
Clinical outcomes of stage-IV non–small-cell lung cancer in young patients and the impact of tumor markers 2
/r/nsclc, 2023-06-19, 00:02:49
Brief Report: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens 2
/r/nsclc, 2023-06-19, 00:02:07
Exosomal Long Noncoding RNAs in NSCLC: Dysfunctions and Clinical Potential 2
/r/nsclc, 2023-06-19, 00:00:40
A Label-Free and Antibody-Free Molecularly Imprinted Polymer-Based Impedimetric Sensor for NSCLC-Cells-Derived Exosomes Detection 2
/r/nsclc, 2023-06-19, 00:00:20
Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting 1
/r/nsclc, 2023-06-14, 18:24:41
Checkpoint inhibitors in older patients with advanced non-small cell lung cancer 1
/r/nsclc, 2023-06-13, 23:05:49
Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management 1
/r/nsclc, 2023-06-13, 23:05:11
Pneumonitis with combined immune checkpoint inhibitors and chemoradiotherapy in locally advanced non-small-cell lung cancer: a systematic review and meta-analysis | Future Oncology 1
/r/nsclc, 2023-06-13, 23:04:36
Molecular correlation of response to pyrotinib in advanced NSCLC with HER2 mutation: biomarker analysis from two phase II trials 1
/r/nsclc, 2023-06-13, 23:01:42
Exceptional response to lorlatinib and cabozantinib in ROS1-rearranged NSCLC with acquired F2004V and L2086F resistance 1
/r/nsclc, 2023-06-13, 23:01:19
Need more results? Sign In or Register
/r/nsclc, 2023-07-28, 14:01:54 , 1 score , +0.42 sentiment rating

Permalink
/r/nsclc, 2023-07-28, 13:41:14 , 2 score , -0.98 sentiment rating

Permalink
/r/nsclc, 2023-06-07, 10:48:27 , 1 score , +0.56 sentiment rating

Permalink
/r/nsclc, 2023-06-07, 04:33:18 , 1 score , -0.92 sentiment rating

Permalink
/r/nsclc, 2023-06-06, 21:05:35 , 1 score , +0.56 sentiment rating

Permalink
/r/nsclc, 2023-06-04, 00:45:57 , 1 score

Permalink
/r/nsclc, 2023-06-03, 13:19:26 , 1 score

Permalink
/r/nsclc, 2023-06-03, 09:21:13 , 1 score , +0.71 sentiment rating

Permalink
/r/nsclc, 2023-06-03, 09:00:42 , 1 score

Permalink
/r/nsclc, 2023-05-30, 18:20:03 , 1 score , +0.40 sentiment rating

Permalink
/r/nsclc, 2023-05-30, 13:40:49 , 1 score

Permalink
/r/nsclc, 2023-05-30, 13:40:19 , 1 score , +0.17 sentiment rating

Permalink
/r/nsclc, 2023-05-03, 19:03:50 , 1 score

Permalink
/r/nsclc, 2023-04-30, 18:39:50 , 3 score , -0.13 sentiment rating

Permalink
/r/nsclc, 2023-04-14, 20:10:31 , 1 score , +0.59 sentiment rating

Permalink
/r/nsclc, 2023-03-14, 11:57:11 , 1 score

Permalink
/r/nsclc, 2023-03-12, 01:32:07 , 1 score , +0.66 sentiment rating

Permalink
/r/nsclc, 2023-03-09, 16:04:50 , 1 score

Permalink
/r/nsclc, 2023-03-09, 14:48:21 , 1 score

Permalink
/r/nsclc, 2023-03-03, 04:00:24 , 1 score

Permalink
/r/nsclc, 2023-01-29, 15:08:53 , 1 score , +0.61 sentiment rating

Permalink
/r/nsclc, 2023-01-29, 12:55:03 , 1 score , +0.90 sentiment rating

Permalink
/r/nsclc, 2023-01-29, 03:41:31 , 1 score , +0.44 sentiment rating

Permalink
/r/nsclc, 2023-01-29, 02:50:04 , 3 score , -0.19 sentiment rating

Permalink
/r/nsclc, 2023-01-10, 05:09:34 , 1 score

Permalink
Need more results? Sign In or Register

Query breakdown by source domain

Query breakdown by subreddit comments

Query breakdown by subreddit posts

API examples
Posts:
curl "https://socialgrep.com/api/v1/search/posts?query=%2Fr%2Fnsclc" -H "Accept: application/json" -H "Authorization: Bearer YOUR_KEY"
Comments:
curl "https://socialgrep.com/api/v1/search/comments?query=%2Fr%2Fnsclc" -H "Accept: application/json" -H "Authorization: Bearer YOUR_KEY"
For more information, see the API Reference page.

Quick Actions

Query breakdown by source domain

Query breakdown by subreddit comments

Query breakdown by subreddit posts

API examples
Posts:
curl "https://socialgrep.com/api/v1/search/posts?query=%2Fr%2Fnsclc" -H "Accept: application/json" -H "Authorization: Bearer YOUR_KEY"
Comments:
curl "https://socialgrep.com/api/v1/search/comments?query=%2Fr%2Fnsclc" -H "Accept: application/json" -H "Authorization: Bearer YOUR_KEY"
For more information, see the API Reference page.

© Lexyr Inc. 2020-2024 • Terms of Service • Cookie Policy • Privacy Policy